Market revenue in 2023 | USD 425.9 million |
Market revenue in 2030 | USD 1,181.5 million |
Growth rate | 15.7% (CAGR from 2023 to 2030) |
Largest segment | On-body |
Fastest growing segment | Off-body |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | On-body, Off-body |
Key market players worldwide | BD, Johnson & Johnson, Roche Holding AG, United Therapeutics Corp, Amgen Inc, Insulet Corp, West Pharmaceutical Services Inc, CeQur Simplicity, Unilife Corporation, Enable Injections |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wearable injectors market will help companies and investors design strategic landscapes.
On-body was the largest segment with a revenue share of 53.46% in 2023. Horizon Databook has segmented the China wearable injectors market based on on-body, off-body covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of chronic disorders and rising geriatric population are some of the major factors contributing to growth of China wearable injectors market. In China, According to a UN report, the elderly population will increase twofold from 10% in 2017 to 20% by 2037. As a result of these factors, the demand for wearable injectors in China is expected to grow over time.
Moreover, increasing incidence of neurological diseases, such as Alzheimer’s disease & multiple sclerosis, impels the risk of aspiration & dehydration. For instance, as per a population-based study, the prevalence of multiple sclerosis was 0.77 cases per 100,000 population, and the prevalence was higher in Chinese women than men, as of August 2022.
In addition, according to a nationwide crossstudy in 2020, the prevalence of dementia/Alzheimer’s disease among people aged 60 and older was 6.0% of the general population. Thus, growing prevalence of chronic diseases is anticipated to fuel the wearable injectors market during the projected timeframe.
Horizon Databook provides a detailed overview of country-level data and insights on the China wearable injectors market , including forecasts for subscribers. This country databook contains high-level insights into China wearable injectors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account